RGC
AMN icon

Roberts, Glore & Co’s AMN Healthcare AMN Stock Holding History

Roberts, Glore & Co’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,820
Closed -$203K – 218
2025
Q2 		$203K Sell
9,820
-1,645
-14% -$34.2K 0.06% 199
2025
Q1 		$280K Sell
11,465
-910
-7% -$23.4K 0.09% 165
2024
Q4 		$296K Sell
12,375
-1,585
-11% -$50.4K 0.09% 169
2024
Q3 		$592K Buy
13,960
+2,865
+26% +$150K 0.17% 113
2024
Q2 		$568K Buy
11,095
+3,925
+55% +$222K 0.17% 114
2024
Q1 		$448K Buy
+7,170
New +$488K 0.13% 128

Other funds holding AMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Roberts, Glore & Co's AMN Position: Q3 2025 in Review

Roberts, Glore & Co sold out of AMN Healthcare (AMN) in Q3 2025, closing a stake of 9,820 shares — an estimated $203K sold.

Roberts, Glore & Co first reported a position in AMN in Q1 2024 and held it in 6 quarters. The position peaked at $592K in Q3 2024. 249 funds tracked by Wall St. Rank hold AMN as of Q3 2025.

  • Roberts, Glore & Co reported no remaining AMN Healthcare position as of Q3 2025 after selling out during the quarter.
  • Roberts, Glore & Co sold 9,820 AMN Healthcare shares in Q3 2025, an estimated $203K.
  • Roberts, Glore & Co first reported a position in AMN Healthcare in Q1 2024 and held it in 6 quarters.
  • Roberts, Glore & Co's AMN Healthcare position peaked at $592K in Q3 2024.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2025.

Based on Roberts, Glore & Co's 13F filing for Q3 2025, filed 12 Nov 2025.